Harmony Biosciences Holdings (HRMY) EBT Growth (1y) (2020 - 2026)
Harmony Biosciences Holdings (HRMY) EBT Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -51.60% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -79.57% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -313.33% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 71.54% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -30.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.59% |
| Dec 31, 2025 | -27.42% |
| Sep 30, 2025 | 8.56% |
| Jun 30, 2025 | 128.81% |
| Mar 31, 2025 | 10.41% |
| Dec 31, 2024 | 41.49% |
| Sep 30, 2024 | 19.95% |
| Jun 30, 2024 | -50.80% |
| Mar 31, 2024 | 37.07% |
| Dec 31, 2023 | -10.01% |
| Sep 30, 2023 | 550.58% |
| Jun 30, 2023 | 50.85% |
| Mar 31, 2023 | 61.56% |
| Dec 31, 2022 | 80.20% |
| Sep 30, 2022 | 175.72% |
| Jun 30, 2022 | 81.68% |
| Mar 31, 2022 | 216.61% |
| Dec 31, 2021 | 11,866.83% |
| Sep 30, 2021 | -651.18% |
| Jun 30, 2021 | 59,688.89% |